369 related articles for article (PubMed ID: 24585742)
1. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic cardiomyopathy mutations increase myofilament Ca
Robinson P; Liu X; Sparrow A; Patel S; Zhang YH; Casadei B; Watkins H; Redwood C
J Biol Chem; 2018 Jul; 293(27):10487-10499. PubMed ID: 29760186
[TBL] [Abstract][Full Text] [Related]
3. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
[TBL] [Abstract][Full Text] [Related]
4. Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
Gaffin RD; Peña JR; Alves MS; Dias FA; Chowdhury SA; Heinrich LS; Goldspink PH; Kranias EG; Wieczorek DF; Wolska BM
J Mol Cell Cardiol; 2011 Nov; 51(5):812-20. PubMed ID: 21840315
[TBL] [Abstract][Full Text] [Related]
5. Ablation of plasma membrane Ca(2+)-ATPase isoform 4 prevents development of hypertrophy in a model of hypertrophic cardiomyopathy.
Prasad V; Lorenz JN; Lasko VM; Nieman ML; Jiang M; Gao X; Rubinstein J; Wieczorek DF; Shull GE
J Mol Cell Cardiol; 2014 Dec; 77():53-63. PubMed ID: 25280781
[TBL] [Abstract][Full Text] [Related]
6. Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca
Sparrow AJ; Watkins H; Daniels MJ; Redwood C; Robinson P
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H715-H722. PubMed ID: 32083971
[TBL] [Abstract][Full Text] [Related]
7. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy.
Wilder T; Ryba DM; Wieczorek DF; Wolska BM; Solaro RJ
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1720-30. PubMed ID: 26432840
[TBL] [Abstract][Full Text] [Related]
9. Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations.
Sparrow AJ; Sievert K; Patel S; Chang YF; Broyles CN; Brook FA; Watkins H; Geeves MA; Redwood CS; Robinson P; Daniels MJ
Circ Res; 2019 Apr; 124(8):1228-1239. PubMed ID: 30732532
[TBL] [Abstract][Full Text] [Related]
10. Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate.
Papadaki M; Vikhorev PG; Marston SB; Messer AE
Cardiovasc Res; 2015 Oct; 108(1):99-110. PubMed ID: 26109583
[TBL] [Abstract][Full Text] [Related]
11. Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice.
McKee LA; Chen H; Regan JA; Behunin SM; Walker JW; Walker JS; Konhilas JP
Arch Biochem Biophys; 2013 Jul; 535(1):39-48. PubMed ID: 23352598
[TBL] [Abstract][Full Text] [Related]
12. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
14. Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).
Warren CM; Karam CN; Wolska BM; Kobayashi T; de Tombe PP; Arteaga GM; Bos JM; Ackerman MJ; Solaro RJ
Circ Cardiovasc Genet; 2015 Dec; 8(6):765-73. PubMed ID: 26553696
[TBL] [Abstract][Full Text] [Related]
15. Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
Bayliss CR; Jacques AM; Leung MC; Ward DG; Redwood CS; Gallon CE; Copeland O; McKenna WJ; Dos Remedios C; Marston SB; Messer AE
Cardiovasc Res; 2013 Mar; 97(3):500-8. PubMed ID: 23097574
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.
Ryba DM; Warren CM; Karam CN; Davis RT; Chowdhury SAK; Alvarez MG; McCann M; Liew CW; Wieczorek DF; Varga P; Solaro RJ; Wolska BM
Circ Heart Fail; 2019 Nov; 12(11):e005835. PubMed ID: 31684756
[TBL] [Abstract][Full Text] [Related]
17. Loss of the AE3 anion exchanger in a hypertrophic cardiomyopathy model causes rapid decompensation and heart failure.
Al Moamen NJ; Prasad V; Bodi I; Miller ML; Neiman ML; Lasko VM; Alper SL; Wieczorek DF; Lorenz JN; Shull GE
J Mol Cell Cardiol; 2011 Jan; 50(1):137-46. PubMed ID: 21056571
[TBL] [Abstract][Full Text] [Related]
18. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.
Fraysse B; Weinberger F; Bardswell SC; Cuello F; Vignier N; Geertz B; Starbatty J; Krämer E; Coirault C; Eschenhagen T; Kentish JC; Avkiran M; Carrier L
J Mol Cell Cardiol; 2012 Jun; 52(6):1299-307. PubMed ID: 22465693
[TBL] [Abstract][Full Text] [Related]
19. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
Robinson P; Griffiths PJ; Watkins H; Redwood CS
Circ Res; 2007 Dec; 101(12):1266-73. PubMed ID: 17932326
[TBL] [Abstract][Full Text] [Related]
20. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
Gomes AV; Harada K; Potter JD
J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
